Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype. - Ning, Xuerao; Nguyễn, Thảo Thi Thanh; Morinaga, Takao; Tada, Yuji; Shimada, Hideaki; Hiroshima, Kenzo; Yamaguchi, Naoto; Tagawa, Masatoshi (PLoS ONE, 2026)